SERES THERAPEUTICS INC revenue breakdown overview

SERES THERAPEUTICS INC revenue for the last year amounted to 114.45 M EUR, the most of which — 114.45 M EUR — came from its highest performing source at the moment, Microbiome Therapeutics, the year earlier bringing 6.66 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought SERES THERAPEUTICS INC 114.45 M EUR, and the year before that — 6.66 M EUR.